UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 431

Sortiert nach

Targeting the methylome to improve CLL outcome

Blood, 2023-07, Vol.142 (1), p.4

Gribben, John G

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular Hematology

Drew Provan, John Gribben / Drew Provan, John Gribben

Fourth edition, 2019

Link zum Volltext

Verfügbarkeit prüfen

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion

Haematologica (Roma), 2023-04, Vol.108 (4), p.1068-1082

2023

Link zum Volltext

Verfügbarkeit prüfen

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1236-1241

2014

Link zum Volltext

Verfügbarkeit prüfen

The EBMT/EHA CAR-T Cell Handbook

1st ed. 2022., 2022

Link zum Volltext

Verfügbarkeit prüfen

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

The Journal of clinical investigation, 2024-02, Vol.134 (4)

2024

Link zum Volltext

Verfügbarkeit prüfen

Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD

Blood, 2021-02, Vol.137 (5), p.702-717

2021

Link zum Volltext

Verfügbarkeit prüfen

NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma

Blood advances, 2022-09, Vol.6 (17), p.5152-5159

2022

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma

Clinical lymphoma, myeloma and leukemia, 2024-05, Vol.24 (5), p.e191-e195.e6

2024

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1584, p.533

2017

Link zum Volltext

Verfügbarkeit prüfen

XV. Clinical aspects of transformed lymphoma

Hematological oncology, 2015-06, Vol.33 (S1), p.80-83

Gribben, John G.

2015

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous cryptococcosis in Hodgkin lymphoma

British journal of haematology, 2014-02, Vol.164 (4), p.467-467

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling in CLL

Hematology, 2008, Vol.2008 (1), p.444-449

Gribben, John G

2008

Link zum Volltext

Verfügbarkeit prüfen

P1253: REDUCED EXPRESSION OF THE CHEMOKINES CXCL2, CXCL3 AND CXCL8 PROVIDES A POTENTIAL MECHANISM PROMOTING IMMUNE EVASION FACILITATING AML RELAPSE FOLLOWING ALLOGENEIC HSCT

HemaSphere, 2023-08, Vol.7 (S3), p.e0435780-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P1254: BASELINE HLA‐DR‐RESTRICTED NEOANTIGEN BURDEN OF AML BLASTS IMPACTS ON HLA‐DR GENE EXPRESSION AT RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT

HemaSphere, 2023-08, Vol.7 (S3), p.e3541969-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma

Leukemia, 2019-06, Vol.33 (6), p.1540-1540

2019

Link zum Volltext

Verfügbarkeit prüfen

S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T‐CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT

HemaSphere, 2023-08, Vol.7 (S3), p.e63003a8-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Are prognostic factors in CLL overrated?

Oncology (Williston Park, N.Y.), 2011-07, Vol.25 (8), p.703, 706-706

Gribben, John G

2011

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of PD-L1/PD-1–mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model

Blood, 2015-07, Vol.126 (2), p.212-221

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapeutic approaches have the potential to brighten the future not only for patients with del(17p13.1), but for all CLL patients

Oncology (Williston Park, N.Y.), 2012-11, Vol.26 (11), p.1055, 1058

2012

Link zum Volltext

Verfügbarkeit prüfen

Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer

JAMA network open, 2020-10, Vol.3 (10), p.e2019304-e2019304

2020

Link zum Volltext

Verfügbarkeit prüfen

Transplantation in Chronic Lymphocytic Leukemia

Hematology/oncology clinics of North America, 2014-12, Vol.28 (6), p.1055-1071

2014

Link zum Volltext

Verfügbarkeit prüfen

Precision Cancer Therapies, Immunologic Approaches for the Treatment of Lymphoid Malignancies: From Concept to Practice

1, 2024

Link zum Volltext

Verfügbarkeit prüfen

Salvage therapy for CLL and the role of stem cell transplantation

Hematology, 2005, Vol.2005 (1), p.292-298

Gribben, John G

2005

Link zum Volltext

Verfügbarkeit prüfen

2.17 Activation of STAT3 Increases Mitochondrial Respiration and Protects Mitochondria from Oxidative Damage in Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S170-S171

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 431

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(401)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(430)
Japanisch
(5)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(29)

Menü

Weitere Dienste

Einstellungen

Targeting the methylome to improve CLL outcome

Molecular Hematology

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

The EBMT/EHA CAR-T Cell Handbook

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD

NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells

XV. Clinical aspects of transformed lymphoma

Cutaneous cryptococcosis in Hodgkin lymphoma

Molecular profiling in CLL

P1253: REDUCED EXPRESSION OF THE CHEMOKINES CXCL2, CXCL3 AND CXCL8 PROVIDES A POTENTIAL MECHANISM PROMOTING IMMUNE EVASION FACILITATING AML RELAPSE FOLLOWING ALLOGENEIC HSCT

P1254: BASELINE HLA‐DR‐RESTRICTED NEOANTIGEN BURDEN OF AML BLASTS IMPACTS ON HLA‐DR GENE EXPRESSION AT RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT

Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma

S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T‐CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT

Are prognostic factors in CLL overrated?

Mechanisms of PD-L1/PD-1–mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model

Immunotherapeutic approaches have the potential to brighten the future not only for patients with del(17p13.1), but for all CLL patients

Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer

Transplantation in Chronic Lymphocytic Leukemia

Precision Cancer Therapies, Immunologic Approaches for the Treatment of Lymphoid Malignancies: From Concept to Practice

Salvage therapy for CLL and the role of stem cell transplantation

2.17 Activation of STAT3 Increases Mitochondrial Respiration and Protects Mitochondria from Oxidative Damage in Chronic Lymphocytic Leukemia

Aktive Filter

Suchergebnisse filtern